UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $2.47M invested in Proshares UltraPro NASDAQ Biotechnology in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less capital invested
Capital invested by funds: $4.37M → $2.47M (-$1.9M)
Holders
7
Holding in Top 10
–
Calls
$589K
Puts
$7K
Top Buyers
| 1 | +$886K | |
| 2 | +$223K | |
| 3 | +$127K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$5K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$2K |
Top Sellers
| 1 | -$651K | |
| 2 | -$322K | |
| 3 | -$250K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$46.6K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$15.8K |